What should you think about when selecting a software solution to support the development of medical devices while considering the Case for Quality and the EU MDR? Tech-Clarity’s Medical Device Manufacturers’ Software Selection Guide helps manufacturers identify the right buying criteria for software solutions to support developing, producing, and servicing medical devices. The guide also
What should Life Sciences companies look for in a solution to help them simultaneously improve profitability and patient outcomes using remote device monitoring via the IoT? Our new Improving Service Performance and Patient Outcomes with Remote Monitoring Buyer’s Guide helps Life Sciences companies understand the business and social value of monitoring equipment with the IoT.
Are you ready for the EU MDR? Tech-Clarity’s Preparing for EU MDR explains the impact of the EU MDR on your product data. While complying to the EU MDR may require an investment, taking the steps now to prepare your product data will not only support EU MDR compliance, but will position your company to
What should Life Sciences Companies look for in a solution to transform service using IoT remote monitoring? Tech-Clarity’s Jim Brown and PTC’s Anthony Moffa will share recent research and industry experience on this Medical Design & Outsourcing webcast, How to Select a Remote Monitoring Solution to Transform Your Service Model. The webcast will cover how
If you are in the medical device industry, are you prepared for the EU MDR? In this on-demand webcast, Tech-Clarity’s Michelle Boucher interviews Caroline Byrd, regulatory expert at Abbott, about the steps Abbott has taken to prepare product data for EU MDR compliance. They discuss: Significant changes between the MDD and MDR How to prioritize
Tech-Clarity research shows that the majority of manufacturers believe that digitalization is important or critical to achieving their business strategy (see figure). Over one-third say that it’s critical. Digitalization in medical device design and manufacturing has significant promise, but what does it actually mean? Medical device companies, already struggling with how to address critical initiatives